Gilead Sciences, Inc. 13D and 13G filings for Allogene Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 4:51 pm Sale | 2021-04-20 | 13G | Allogene Therapeutics, Inc. ALLO | GILEAD SCIENCES INC. GILD | 1,156,689 0.800% | -6,330,000 (-84.55%) | Filing |